CJON Reporter: The Role of the Data Safety Monitoring Board: Why Was the Avastin® Phase III Clinical Trial Stopped?

Monica R. Mclemore

CJON 2006, 10(2), 153-154. DOI: 10.1188/06.CJON.153-154
Members Only
Not a current ONS member or journal subscriber?

Become a Member

Explore the benefits of membership.
Join ONS or Renew Membership

Purchase This Article

Receive a PDF to download and print.